ArticleCureus2025
Retrolental Opacity: Atypical Manifestation of Lens-Induced Uveitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The crystalline lens can cause intraocular inflammation when its capsule is ruptured or allows leakage of lens proteins into the anterior chamber, a condition known as lens-induced uveitis (LIU). LIU is a rare form of uveitis and can be classified based on the integrity of the lens capsule. When the capsule is ruptured, the inflammation is called phacoantigenic or phacoanaphylactic uveitis, whereas if the capsule remains intact but leaks proteins, it is termed phacolytic uveitis. Common causes include ocular trauma, previous surgery, or spontaneous rupture in hypermature cataracts. Initial treatment often involves topical corticosteroids, but surgical intervention is frequently required. We report the case of a 76-year-old male patient with a history of bilateral cataracts and prior cataract surgery in the left eye, who presented with decreased visual acuity and ocular pain in the right eye over several weeks. Examination revealed hand motion vision, normal intraocular pressure, fibrinous membranes in the anterior chamber, and a dense cataract with an intact anterior capsule. Ultrasound and ultrabiomicroscopy demonstrated punctiform echoes organized into a central plasmoid body adhered to the iris and corneal endothelium, in addition to a cataract with a dense and mobile central nucleus, absence of cortex, and an intact anterior capsule. After medical management with topical steroids and nonsteroidal anti-inflammatory drugs to control inflammation, the patient underwent phacoemulsification with intraocular lens implantation. During surgery, a dense Morgagnian cataract with an intact capsule was removed. A whitish opacity behind the lens corresponding to anterior vitreous inflammation was identified and extracted via anterior vitrectomy. Postoperatively, inflammation improved significantly, and at two months, visual acuity recovered to 20/25 with complete resolution of ocular inflammation. This case highlights the clinical presentation and management challenges of LIU, specifically phacolytic uveitis. The presence of a hypermature cataract in an eye without prior surgery or trauma strongly supports this diagnosis. While a phacoantigenic mechanism cannot be entirely excluded, the absence of prior lens capsule violation makes it highly unlikely. Recognizing these atypical inflammatory signs and implementing a combined medical and surgical approach are crucial to preserve vision and prevent complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.